Diabetes decisions — 2025

The Board granted service connection for cervical strain, cervicogenic headaches, right wrist sprain, left elbow disability, right knee degenerative arthritis and right knee strain, and left knee strain. However, it denied service connection for diabetes mellitus, type I, gastroesophageal reflux disease (GERD), hypertension, and remanded claims for chronic fatigue syndrome, right forearm carpal tunnel syndrome, left forearm CTS, a right elbow disability, and a left wrist disability.

The Board granted an effective date of September 3, 2020, for service connection for diabetes mellitus based on the Veteran's timely filed Supplemental Claim Application.

The appeal was dismissed due to the Veteran's death before a final decision could be made.

The motion for reversal or revision of the June 2020 Board decision that denied service connection for diabetes mellitus was denied.

The Board denied service connection for diabetes mellitus, type 2 and denied an initial compensable evaluation for prostate cancer residuals prior to April 3, 2023. However, the Board granted a 10 percent evaluation from April 3, 2023.

The Board denied increased ratings for various diabetic peripheral neuropathies and diabetes mellitus, but granted restoration of a 60 percent rating for diabetic nephropathy and awarded TDIU.

The Board denied the Veteran's claim for service connection for diabetes mellitus as there was no evidence of in-service incurrence or a link to an in-service event, and the condition did not manifest within one year of separation from service.

The Board denied the Veteran's claim for a rating in excess of 20 percent for diabetes mellitus, type II, as the evidence did not show that he required insulin or regulation of activities.

The veteran withdrew the appeals seeking service connection for various conditions, including skin cancer, diabetes mellitus, and peripheral neuropathy.

The Board granted earlier effective dates of June 24, 2011, for the award of service connection for coronary artery disease, diabetes mellitus, and tremors of both upper extremities.

The Board granted a 20 percent rating for diabetes mellitus type II, as the Veteran required insulin and a restricted diet.

The Board granted earlier effective dates for the Veteran's left and right knee instability, as well as a 20% disability rating for erectile dysfunction. Other claims were denied.

The Board remands the claims for readjudication due to new and relevant evidence being received.

The appeal of the issue of entitlement to service connection for ischemic heart disease (IHD) is dismissed, while diabetes mellitus, type II and bilateral hearing loss are granted with specific ratings.

The Board remands the claim for service connection for diabetes due to a pre-decisional duty to assist error, while dismissing the claims for hyperparathyroidism and chronic kidney disease as untimely.

The Veteran's service connection for diabetes was granted, while the higher initial rating and TDIU claims for PTSD were denied.

The Board granted a 40 percent rating for peripheral neuropathy in both the left and right lower extremities but denied an increased rating for diabetes mellitus II with diabetic nephropathy, erectile dysfunction, and hypertension. The Veteran's claim for TDIU was also granted.

The Board remands the claims for service connection for various disabilities, including psychiatric conditions, respiratory issues, diabetes mellitus, and a traumatic head injury, due to incomplete records and inadequate medical examinations.

The Board remands the claims for service connection for prostate cancer and type II diabetes mellitus to correct duty to assist errors related to the PACT Act.

The Board granted service connection for diabetes mellitus type II based on the Veteran's exposure to herbicide agents during active service in Vietnam.